Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 6.18 Million shares of MRNA, which is worth approximately $153 Million. The most recent transaction as insider was on Jan 27, 2021, when has been sold 9,000 shares (Common Stock) at a price of $151.27 per share, resulting in proceeds of $1,361,430. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.18M
12.52% 3M change
12.66% 12M change
Total Value Held $153 Million

Stephane Bancel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 27 2021
SELL
Open market or private sale
$1,361,430 $151.27 p/Share
9,000 Reduced 0.14%
6,474,868 Common Stock
Jan 20 2021
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,483,868 Common Stock
Jan 20 2021
SELL
Open market or private sale
$1,120,590 $124.51 p/Share
9,000 Reduced 0.14%
6,484,868 Common Stock
Jan 13 2021
SELL
Open market or private sale
$1,237,000 $123.7 p/Share
10,000 Reduced 0.15%
6,493,868 Common Stock
Jan 06 2021
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,503,868 Common Stock
Jan 06 2021
SELL
Open market or private sale
$998,640 $110.96 p/Share
9,000 Reduced 0.14%
6,504,868 Common Stock
Dec 30 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,513,868 Common Stock
Dec 30 2020
SELL
Open market or private sale
$1,064,430 $118.27 p/Share
9,000 Reduced 0.14%
6,514,868 Common Stock
Dec 23 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,523,868 Common Stock
Dec 23 2020
SELL
Open market or private sale
$1,080,000 $120.0 p/Share
9,000 Reduced 0.14%
6,524,868 Common Stock
Dec 16 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,533,868 Common Stock
Dec 16 2020
SELL
Open market or private sale
$1,237,590 $137.51 p/Share
9,000 Reduced 0.14%
6,534,868 Common Stock
Dec 09 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,543,868 Common Stock
Dec 09 2020
SELL
Open market or private sale
$1,530,000 $170.0 p/Share
9,000 Reduced 0.14%
6,544,868 Common Stock
Dec 02 2020
SELL
Open market or private sale
$1,247,130 $138.57 p/Share
9,000 Reduced 0.14%
6,554,868 Common Stock
Dec 02 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,553,868 Common Stock
Nov 25 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,563,868 Common Stock
Nov 25 2020
SELL
Open market or private sale
$892,800 $99.2 p/Share
9,000 Reduced 0.14%
6,564,868 Common Stock
Nov 18 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,573,868 Common Stock
Nov 18 2020
SELL
Open market or private sale
$844,830 $93.87 p/Share
9,000 Reduced 0.14%
6,574,868 Common Stock
Nov 12 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,583,868 Common Stock
Nov 11 2020
SELL
Open market or private sale
$693,450 $77.05 p/Share
9,000 Reduced 0.14%
6,584,868 Common Stock
Nov 04 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,593,868 Common Stock
Nov 04 2020
SELL
Open market or private sale
$620,730 $68.97 p/Share
9,000 Reduced 0.14%
6,594,868 Common Stock
Oct 28 2020
SELL
Bona fide gift
-
1,000 Reduced 0.02%
6,603,868 Common Stock
Stephane Bancel

Stephane Bancel

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA